1. Home
  2. MEDP vs ALGN Comparison

MEDP vs ALGN Comparison

Compare MEDP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • ALGN
  • Stock Information
  • Founded
  • MEDP 1992
  • ALGN 1997
  • Country
  • MEDP United States
  • ALGN United States
  • Employees
  • MEDP N/A
  • ALGN N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • ALGN Industrial Specialties
  • Sector
  • MEDP Health Care
  • ALGN Health Care
  • Exchange
  • MEDP Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • MEDP 13.4B
  • ALGN 12.5B
  • IPO Year
  • MEDP 2016
  • ALGN N/A
  • Fundamental
  • Price
  • MEDP $490.77
  • ALGN $131.82
  • Analyst Decision
  • MEDP Hold
  • ALGN Buy
  • Analyst Count
  • MEDP 11
  • ALGN 13
  • Target Price
  • MEDP $424.10
  • ALGN $216.25
  • AVG Volume (30 Days)
  • MEDP 320.7K
  • ALGN 1.3M
  • Earning Date
  • MEDP 10-20-2025
  • ALGN 10-22-2025
  • Dividend Yield
  • MEDP N/A
  • ALGN N/A
  • EPS Growth
  • MEDP 26.42
  • ALGN 0.42
  • EPS
  • MEDP 13.46
  • ALGN 5.92
  • Revenue
  • MEDP $2,231,787,000.00
  • ALGN $3,964,802,000.00
  • Revenue This Year
  • MEDP $19.06
  • ALGN $2.03
  • Revenue Next Year
  • MEDP $8.64
  • ALGN $3.31
  • P/E Ratio
  • MEDP $36.52
  • ALGN $22.33
  • Revenue Growth
  • MEDP 9.94
  • ALGN 0.56
  • 52 Week Low
  • MEDP $250.05
  • ALGN $127.70
  • 52 Week High
  • MEDP $501.30
  • ALGN $262.87
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 62.33
  • ALGN 37.26
  • Support Level
  • MEDP $485.33
  • ALGN $130.84
  • Resistance Level
  • MEDP $498.15
  • ALGN $140.37
  • Average True Range (ATR)
  • MEDP 11.60
  • ALGN 4.02
  • MACD
  • MEDP -1.73
  • ALGN 0.64
  • Stochastic Oscillator
  • MEDP 76.38
  • ALGN 7.88

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: